How iCARE4CVD is advancing personalised cardiovascular care in Europe
Cardiovascular disease remains one of Europe’s most urgent health challenges, affecting more than 85 million people. Through iCARE4CVD, a €22 million public–private collaboration led by Maastricht University and Novo Nordisk,…